Steve Scalise
The Public Record
Steve Scalise is an American politician serving as the U.S. Representative for Louisiana's 1st congressional district since 2008. A member of the Republican Party, Scalise has held significant leadership roles, including serving as the House Majority Whip. Throughout his tenure, he has focused on issues such as tax reform, healthcare, and energy policy, advocating for conservative principles in Congress.
The Biden Administration's immigration policies are exactly the wrong type of action we need to fight drug abuse in this country.
It`s not focused on COVID relief. It`s focused on pushing more of the far left agenda. People recognize that Speaker Pelosi socialist agenda is bad for America.
I say this to let you know that I don't blame those other people, I blame the shooter.
It is a clear example of not only mob violence but also how political discourse can get out of control.
Once the elect -- once the electors are counted, yes, he's the legitimate president.
Look, Joe Biden's the president. There were a few states that did not follow their state laws.
Once the elect once the electors are counted, yes, he's the legitimate president. But if you're going to ignore the fact that there were states that did not follow their own state legislatively set laws, that's the issue at heart.
Look, Joe Biden's the president. There were a few states that did not follow their state laws. That's really the dispute that you've seen continue on.
We're very united in our opposition to the devastating economic hits that President Biden has been doing in his first two weeks.
We're very united in our opposition to the devastating economic hits that President Biden has been doing in his first two weeks.
We’re going to be talking through a lot of these issues internally. Look, first of all, we’re very united in our opposition to the devastating economic hits that President Biden has been doing in his first two weeks.
I thank the gentleman for yielding. As the gentleman from Maryland pointed out, we know government funding expires at midnight. Clearly, we have been working for days in a very productive way to get close to an agreement on both funding of…
I thank the gentleman, and I will continue to work on these items that we need to get resolved--hopefully, will get resolved--in the coming days. Mr. Speaker, I yield back the balance of my time. ____________________
I thank the gentleman. Clearly, President Trump has expressed his concerns about some items in and not in the National Defense Authorization Act. Ultimately, we will see soon if he signs it or vetoes it. He has, obviously, got to weigh all…
I thank the gentleman, and I hope we get those answers. These are serious questions that have been raised. And we are talking about a committee that deals with the most sensitive intelligence information. In fact, most Members of Congress…
If we wanted to pass another CARES Act-type piece of legislation, as we have seen in both other CARES Act bills, you have a lot of willingness and interest on this side of the aisle, which was there on both of those votes. Clearly, there…
I thank the gentleman, too. In terms of our children, we know sending them back to school safely, the protocols are out there. Child nutrition programs are administered in our schools. That is not happening because the kids are in those…
I will give this assurance to the majority leader, that if you are looking for a replacement, I would be happy to provide recommendations and even participate in the interview process, if that would be helpful to the gentleman from…
I thank the gentleman. There are a few items relating to legislation that I want to bring up with the gentleman, but before that, I did want to mention that it is my understanding that the floor director for the majority leader, Ms…
I rise for the purpose of inquiring to the majority leader the schedule for next week. Mr. Speaker, I yield to the gentleman from Maryland (Mr. Hoyer), my friend and the majority leader of the House.
There has been a plan that started early off in this pandemic, and it continues to grow and change as we learn more about the disease.
This is historic and unprecedented that we are--at the same time that we're advancing the development to demonstrate safety and efficacy, we're literally making, as we speak, we have millions of doses of vaccine.





